Skip to main content

Breast Cancer Statistics

  • Chapter
  • First Online:

Abstract

Among U.S. women, breast cancer is the most commonly diagnosed cancer (excluding skin cancers) and the second leading cause of cancer death, following lung cancer. In 2012, an estimated 226,870 new cases of invasive breast cancer and 39,510 breast cancer deaths are expected to occur among U.S. women. Breast cancer rates vary largely by race/ethnicity and socioeconomic status (SES), and geographic region. Death rates are higher in African American women than in whites, despite their lower incidence rates. Historically, breast cancer was recognized as a disease of western countries. However, over the past 20 years, breast cancer incidence and mortality rates have been increasing rapidly in economically less developed regions. According to 2008 GLOBOCAN estimates, half of the new worldwide breast cancer cases (1.38 million) and 60 % of the breast cancer deaths (458,000) occurred in developing countries. This chapter reviews breast cancer incidence and mortality patterns among women in the U.S. and worldwide, and the possible explanations for these patterns.

Keywords

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics. CA Cancer J Clin 62(1):10–29

    Article  PubMed  Google Scholar 

  2. Jemal A, Center MM, DeSantis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer epidemiology, biomarkers and prevention: A publication of the American association for cancer research, cosponsored by the American society of preventive oncology 19(8):1893–1907

    Google Scholar 

  3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917

    Article  PubMed  CAS  Google Scholar 

  4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90

    Article  PubMed  Google Scholar 

  5. Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R et al (2008) Cancer survival in five continents: a worldwide population-based study. Lancet Oncol 9(8):730–756

    Article  PubMed  Google Scholar 

  6. Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA (2010) Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst 102(20):1584–1598

    Article  PubMed  Google Scholar 

  7. NAACCR (2011) Surveillance, epidemiology and end results (SEER) program database (2011) CiNA Analytic File, 1995–2008, for expanded races, custom file with county, ACS facts and figures projection project, North American association of central cancer registries.www.seer.cancer.gov. Assessed 2011

  8. National Cancer Institute (2012) SEER Surveillance, epidemiology, and end results registries. http://seer.cancer.gov/registries/index.html. Assessed 19 April 2012

  9. National Program of Cancer Registries (2012) Centers for disease control and prevention. http://www.cdc.gov/cancer/npcr/about.htm. Assessed 6 April 2012

  10. SEER (2011) Surveillance, epidemiology, and end results (SEER) program database www.seer.cancer.gov National cancer institute, DCCPS, surveillance research program, surveillance systems branch. Assessed April 2011

  11. German RR, Fink AK, Heron M, Stewart SL, Johnson CJ, Finch JL et al (2011) The accuracy of cancer mortality statistics based on death certificates in the United States. Cancer Epidemiol 35(2):126–131

    Article  PubMed  Google Scholar 

  12. GLOBOCAN 2008 v1.2 (2010) Cancer incidence and mortality worldwide: IARC CancerBase No. 10. International agency for research on cancer. http://globocan.iarc.fr.Assessed 20, April 2012

  13. Parkin DM (2006) The evolution of the population-based cancer registry. Nat Rev Cancer 6(8):603–612

    Article  PubMed  CAS  Google Scholar 

  14. Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15(1):36–47

    PubMed  CAS  Google Scholar 

  15. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W et al (2011) SEER cancer statistics review, 1975–2008. National Cancer Institute Bethesda, Maryland

    Google Scholar 

  16. Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M (2003) Trends in breast cancer by race and ethnicity. CA Cancer J Clin 53(6):342–355

    Article  PubMed  Google Scholar 

  17. Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D et al (2005) Ethnicity and breast cancer: Factors influencing differences in incidence and outcome. J Natl Cancer Inst 97(6):439–448

    Article  PubMed  Google Scholar 

  18. Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163(1):49–56

    Article  PubMed  Google Scholar 

  19. Hershman D, Weinberg M, Rosner Z, Alexis K, Tiersten A, Grann VR et al (2003) Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst 95(20):1545–1548

    Article  PubMed  Google Scholar 

  20. Gerend MA, Pai M (2008) Social determinants of Black-White disparities in breast cancer mortality: A review. Cancer epidemiology, biomarkers and prevention: A publication of the American association for cancer research, cosponsored by the American society of preventive oncology 17(11):2913–2923

    Google Scholar 

  21. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K et al (2006) Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA 295(21):2492–2502

    Article  PubMed  CAS  Google Scholar 

  22. DeSantis C, Jemal A, Ward E (2010) Disparities in breast cancer prognostic factors by race, insurance status, and education. Cancer Causes Control 21(9):1445–1450

    Article  PubMed  Google Scholar 

  23. Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD et al (2009) Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: national longitudinal mortality study. Cancer Causes Control 20(4):417–435

    Article  PubMed  Google Scholar 

  24. Singh GK, Miller BA, Hankey BF, Edwards BK (2003) Area socioeconomic variations in U.S. Cancer incidence, mortality, stage, treatment, and survival, 1975–1999. NCI cancer surveillance monograph series, number 4. Bethesda, Maryland

    Google Scholar 

  25. Klassen AC, Smith KC (2011) The enduring and evolving relationship between social class and breast cancer burden: a review of the literature. Cancer Epidemiol 35(3):217–234

    Article  PubMed  Google Scholar 

  26. Desantis C, Siegel R, Bandi P, Jemal A (2011) Breast cancer statistics. CA Cancer J Clin 61(6):409–418

    Article  PubMed  Google Scholar 

  27. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61(4):212–236

    Article  PubMed  Google Scholar 

  28. Polednak AP (2005) Explaining geographic variation in breast and cervical cancer incidence rates in US Hispanic women. Ethn Dis 15(4):727–732

    PubMed  Google Scholar 

  29. Laden F, Spiegelman D, Neas LM, Colditz GA, Hankinson SE, Manson JE et al (1997) Geographic variation in breast cancer incidence rates in a cohort of U.S. women. J Natl Cancer Inst 89(18):1373–1378

    Article  PubMed  CAS  Google Scholar 

  30. Canto MT, Anderson WF, Brawley O (2001) Geographic variation in breast cancer mortality for white and black women: 1986–1995. CA Cancer J Clin 51(6):367–370

    Article  PubMed  CAS  Google Scholar 

  31. Sturgeon SR, Schairer C, Gail M, McAdams M, Brinton LA, Hoover RN (1995) Geographic variation in mortality from breast cancer among white women in the United States. J Natl Cancer Inst 87(24):1846–1853

    Article  PubMed  CAS  Google Scholar 

  32. Kalager M, Adami HO, Bretthauer M, Tamimi RM (2012) Overdiagnosis of invasive breast cancer due to mammography screening: results from the norwegian screening program. Ann of int med 156(7):491–499

    Google Scholar 

  33. Wun LM, Feuer EJ, Miller BA (1995) Are increases in mammographic screening still a valid explanation for trends in breast cancer incidence in the United States? Cancer Causes Control 6(2):135–144

    Article  PubMed  CAS  Google Scholar 

  34. Glass AG, Lacey JV Jr, Carreon JD, Hoover RN (2007) Breast cancer incidence, 1980–2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 99(15):1152–1161

    Article  PubMed  Google Scholar 

  35. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ et al (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356(16):1670–1674

    Article  PubMed  CAS  Google Scholar 

  36. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s health Initiative randomized controlled trial. JAMA 288(3):321–333

    Article  PubMed  CAS  Google Scholar 

  37. Jemal A, Ward E, Thun MJ (2007) Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 9(3):R28

    Article  PubMed  Google Scholar 

  38. DeSantis C, Howlader N, Cronin KA, Jemal A (2011) Breast cancer incidence rates in U.S. women are no longer declining. Cancer epidemiology, biomarkers and prevention: a publication of the American association for cancer research, cosponsored by the American society of preventive oncology 20(5):733–739

    Google Scholar 

  39. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M et al (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353(17):1784–1792

    Article  PubMed  CAS  Google Scholar 

  40. Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y et al (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26(20):3324–3330

    Article  PubMed  Google Scholar 

  41. CANCERMondial (2012) International agency for cancer research. http://www-dep.iarc.fr. Assessed 20, April 2012

  42. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW et al (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85(22):1819–1827

    Article  PubMed  CAS  Google Scholar 

  43. Tominaga S (1985) Cancer incidence in Japanese in Japan, Hawaii, and western United States. Natl Cancer Inst Monogr 69:83–92

    PubMed  CAS  Google Scholar 

  44. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds) (2002) Cancer incidence in five continents, vol 8. Lyon, France

    Google Scholar 

  45. Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14(2):185–187

    Article  PubMed  CAS  Google Scholar 

  46. Parkin DM, Nambooze S, Wabwire-Mangen F, Wabinga HR (2010) Changing cancer incidence in Kampala, Uganda, 1991–2006. Int J Cancer 126(5):1187–1195

    PubMed  CAS  Google Scholar 

  47. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA (2005) Global trends in breast cancer incidence and mortality 1973–1997. Int J Epidemiol 34(2):405–412

    Article  PubMed  Google Scholar 

  48. Parkin DM (2009) Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy? Eur J Cancer 45(9):1649–1653

    Article  PubMed  Google Scholar 

  49. Seradour B, Allemand H, Weill A, Ricordeau P (2009) Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006. Bull Cancer 96(4):E1–E6

    PubMed  CAS  Google Scholar 

  50. Canfell K, Banks E, Moa AM, Beral V (2008) Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Aust 188(11):641–644

    PubMed  Google Scholar 

  51. Peto R, Boreham J, Clarke M, Davies C, Beral V (2000) UK and USA breast cancer deaths down 25 % in year 2000 at ages 20–69 years. Lancet 355(9217):1822

    Article  PubMed  CAS  Google Scholar 

  52. Anderson BO, Yip CH, Smith RA, Shyyan R, Sener SF, Eniu A et al (2008) Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the breast health global initiative global summit. Cancer 113(8):2221–22243

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmedin Jemal .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ma, J., Jemal, A. (2013). Breast Cancer Statistics. In: Ahmad, A. (eds) Breast Cancer Metastasis and Drug Resistance. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5647-6_1

Download citation

Publish with us

Policies and ethics